Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max J Hyman

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JAMA Health Forum|December 21, 2023
Industry Payments for Vibegron and Prescribing Patterns Among Urologic CliniciansKayla Polcari, Max J Hyman, Ted A Skolarus, et al.
JAMA Ophthalmology|November 29, 2023
Metformin Use and Age-Related Macular Degeneration in Patients Without DiabetesSarthak Aggarwal, John Moir, Max J Hyman, et al.
Retina (Philadelphia, Pa.)|January 23, 2024
ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENTSaira Khanna, Lincoln Shaw, Max J Hyman, et al.
Urology|April 25, 2024
Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and UrologistsMax J Hyman, Ted A Skolarus, Joshua Cabral, et al.
Ophthalmology Science|October 27, 2025
Early Antibiotic Use and Retinopathy of Prematurity: A Single-Center Retrospective Cohort StudyJason Y Zhang, Deborah S Bondi, Max J Hyman, et al.
Urology|July 30, 2023
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021Sawyer Reed, Armaan Singh, Max J Hyman, et al.
Ophthalmology. Retina|May 5, 2023
Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular DegenerationMax J Hyman, Dimitra Skondra, Nitika Aggarwal, et al.
Urology|August 2, 2025
Contemporary Trends in the Management of Urethral Stricture Disease in the Era of the AUA GuidelinesJoshua D Cabral, Marwan Alkassis, Kareim Khalafalla, et al.
Retina (Philadelphia, Pa.)|October 2, 2023
INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETESLincoln Shaw, Saira Khanna, Max J Hyman, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 13, 2026
Association Between Metformin and Other Diabetic Medications and Five-year Onset of New Neovascular Age-related Macular Degeneration DiagnosisChristopher M Maatouk, Max J Hyman, Arjav Shah, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JAMA Health Forum|December 21, 2023
Industry Payments for Vibegron and Prescribing Patterns Among Urologic CliniciansKayla Polcari, Max J Hyman, Ted A Skolarus, et al.
JAMA Ophthalmology|November 29, 2023
Metformin Use and Age-Related Macular Degeneration in Patients Without DiabetesSarthak Aggarwal, John Moir, Max J Hyman, et al.
Retina (Philadelphia, Pa.)|January 23, 2024
ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENTSaira Khanna, Lincoln Shaw, Max J Hyman, et al.
Urology|April 25, 2024
Utilization and Timing of Cystoscopy for Hematuria Evaluation by Advanced Practice Providers and UrologistsMax J Hyman, Ted A Skolarus, Joshua Cabral, et al.
Ophthalmology Science|October 27, 2025
Early Antibiotic Use and Retinopathy of Prematurity: A Single-Center Retrospective Cohort StudyJason Y Zhang, Deborah S Bondi, Max J Hyman, et al.
Urology|July 30, 2023
Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021Sawyer Reed, Armaan Singh, Max J Hyman, et al.
Ophthalmology. Retina|May 5, 2023
Levodopa Is Associated with Reduced Development of Neovascular Age-Related Macular DegenerationMax J Hyman, Dimitra Skondra, Nitika Aggarwal, et al.
Urology|August 2, 2025
Contemporary Trends in the Management of Urethral Stricture Disease in the Era of the AUA GuidelinesJoshua D Cabral, Marwan Alkassis, Kareim Khalafalla, et al.
Retina (Philadelphia, Pa.)|October 2, 2023
INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETESLincoln Shaw, Saira Khanna, Max J Hyman, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 13, 2026
Association Between Metformin and Other Diabetic Medications and Five-year Onset of New Neovascular Age-related Macular Degeneration DiagnosisChristopher M Maatouk, Max J Hyman, Arjav Shah, et al.
Pageof 5